146 related articles for article (PubMed ID: 7510938)
1. Tumor-associated angiogenesis in prostate cancer.
Fregene TA; Khanuja PS; Noto AC; Gehani SK; Van Egmont EM; Luz DA; Pienta KJ
Anticancer Res; 1993; 13(6B):2377-81. PubMed ID: 7510938
[TBL] [Abstract][Full Text] [Related]
2. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
[TBL] [Abstract][Full Text] [Related]
3. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner N; Carroll PR; Flax J; Blumenfeld W; Folkman J
Am J Pathol; 1993 Aug; 143(2):401-9. PubMed ID: 7688183
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
[TBL] [Abstract][Full Text] [Related]
6. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M
J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor expression and angiogenesis in human prostate carcinoma.
Abdulkadir SA; Carvalhal GF; Kaleem Z; Kisiel W; Humphrey PA; Catalona WJ; Milbrandt J
Hum Pathol; 2000 Apr; 31(4):443-7. PubMed ID: 10821491
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density in prostate carcinoma.
Bono AV; Celato N; Cova V; Salvadore M; Chinetti S; Novario R
Prostate Cancer Prostatic Dis; 2002; 5(2):123-7. PubMed ID: 12497001
[TBL] [Abstract][Full Text] [Related]
9. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI
Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487
[TBL] [Abstract][Full Text] [Related]
11. The relationship between angiogenesis and cyclooxygenase-2 expression in prostate cancer.
Mukherjee R; Edwards J; Underwood MA; Bartlett JM
BJU Int; 2005 Jul; 96(1):62-6. PubMed ID: 15963122
[TBL] [Abstract][Full Text] [Related]
12. Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
van Niekerk CG; van der Laak JA; Börger ME; Huisman HJ; Witjes JA; Barentsz JO; Hulsbergen-van de Kaa CA
Prostate; 2009 Jan; 69(1):62-9. PubMed ID: 18780292
[TBL] [Abstract][Full Text] [Related]
13. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer.
Ohta S; Wada H; Nakazaki T; Maeda Y; Nobori T; Shiku H; Nakamura S; Nagakawa O; Furuya Y; Fuse H
Anticancer Res; 2002; 22(5):2991-6. PubMed ID: 12530031
[TBL] [Abstract][Full Text] [Related]
14. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
[TBL] [Abstract][Full Text] [Related]
16. [Angiogenesis: prognostic marker in prostatic cancer].
Borre M; Offersen IB; Nerstrøm B; Overgaard J
Ugeskr Laeger; 1999 Jun; 161(25):3832-6. PubMed ID: 10412301
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density in prostate cancer: prognostic and therapeutic utility.
Bostwick DG; Iczkowski KA
Semin Urol Oncol; 1998 Aug; 16(3):118-23. PubMed ID: 9741415
[TBL] [Abstract][Full Text] [Related]
18. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
Yang G; Addai J; Wheeler TM; Frolov A; Miles BJ; Kadmon D; Thompson TC
Hum Pathol; 2007 Nov; 38(11):1688-95. PubMed ID: 17707459
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.
Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ
In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042
[TBL] [Abstract][Full Text] [Related]
20. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.
Murphy C; McGurk M; Pettigrew J; Santinelli A; Mazzucchelli R; Johnston PG; Montironi R; Waugh DJ
Clin Cancer Res; 2005 Jun; 11(11):4117-27. PubMed ID: 15930347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
